Chennai Meenakshi Multispeciality Hospital Ltd. has announced that its board of directors will meet on May 25, 2026, to consider the audited financial results for the quarter and fiscal year ended March 31, 2026. The meeting is scheduled to take place at 12:00 Noon at the company's registered office located at New No. 70, Old No.149, Luz Church Road, Mylapore, Chennai - 600 004.

The agenda for the meeting includes the consideration, approval, and recording of the audited financial results for the specified period. This disclosure is made in compliance with Regulation 29(1)(a) and Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015.

In conjunction with the board meeting, the company has informed stakeholders that the trading window for dealing in the company's shares by directors, designated employees, and other insiders remains closed. The closure period began on April 1, 2026, and will continue until 48 hours after the declaration of the financial results for the quarter and year ended March 31, 2026. This measure is in accordance with the company's Code of Prevention of Insider Trading and the SEBI (Prohibition of Insider Trading) Regulations, 2015.

The notice, dated May 13, 2026, was issued by M.S. Anantha Lakshmi, Company Secretary and Compliance Officer for chennai meenakshi multispeciality . The company, formerly known as Devaki Hospital Limited, is ISO 9001:2008 and ISO 14001:2004 certified.

Chennai meenakshi multispeciality Hospital Limited has submitted its quarterly compliance certificate to regulatory authorities, confirming adherence to SEBI depositories regulations for the quarter ended March 31, 2026. The certificate was filed on April 13, 2026, addressing compliance requirements under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018.

Regulatory Compliance Confirmation

The hospital filed the mandatory certificate with both Central Depository Services India Ltd. and National Securities Depository Ltd., confirming proper handling of dematerialization processes during Q4 FY26. Company Secretary and Compliance Officer M.S. Anantha Lakshmi signed the certificate, ensuring regulatory compliance.

Dematerialization Process Verification

The certificate confirms that all securities received for dematerialization during the quarter were processed according to regulatory requirements. Cameo Corporate Services Limited, serving as the company's Registrar and Share Transfer Agent, provided confirmation of proper verification procedures.

Key compliance aspects covered include:

• Securities received for dematerialization were mutilated and cancelled after due verification
• Depository names were substituted in company records as registered owners
• All processes completed within stipulated time limits under SEBI regulations
• Dematerialized securities remain listed on BSE Limited where earlier issued securities are listed

Registrar Confirmation

Cameo Corporate Services Limited issued a separate confirmation letter dated April 1, 2026, verifying compliance with dematerialization requirements. The registrar confirmed that securities received from depository participants during Q4 FY26 were properly accepted or rejected to depositories within regulatory timeframes.

Corporate Information

The hospital operates under CIN L85110TN1990PLC019545 and maintains its registered office at Old No.149, New No. 70, Luz Church Road, Mylapore, Chennai. The facility holds ISO 9001:2008 and ISO 14001:2004 certifications, reflecting its commitment to quality and environmental management standards.

This quarterly filing demonstrates the hospital's ongoing commitment to regulatory compliance and transparent corporate governance practices in accordance with SEBI requirements for listed entities.